(Q45141050)

10 December 2017

title

Inhibition of lymphocyte activation and function by the prenylation inhibitor L-778,123. (English)

1 reference

10 December 2017

Ming-Sing Si

1

1 reference

10 December 2017

Bruce A Reitz

series ordinal

2

1 reference

10 December 2017

Dominic C Borie

series ordinal

3

1 reference

10 December 2017

publication date

1 January 2005

1 reference

Investigational New Drugs

10 December 2017

published in

1 reference

10 December 2017

volume

23

1 reference

10 December 2017

issue

1

1 reference

10 December 2017

page(s)

21-29

1 reference

https://scigraph.springernature.com/pub.10.1023/b:drug.0000047102.26698.08

10 December 2017

exact match

0 references

cites work

Novel assays of multiple lymphocyte functions in whole blood measure: new mechanisms of action of mycophenolate mofetil in vivo

1 reference

12 December 2020

Mycophenolic acid inhibits IL-2-dependent T cell proliferation, but not IL-2-dependent survival and sensitization to apoptosis

1 reference

12 December 2020

Inhibition of actin polymerization enhances commitment to and execution of apoptosis induced by withdrawal of trophic support

1 reference

12 December 2020

Inhibitors of prenylation of Ras and other G-proteins and their application as therapeutics

1 reference

12 December 2020

Farnesyl: proteintransferase inhibitors as agents to inhibit tumor growth

1 reference

12 December 2020

Quantification of immunosuppression by flow cytometry in stable renal transplant recipients

1 reference

12 December 2020

Prenylation inhibitors in renal disease

1 reference

12 December 2020

Interleukin (IL)-2 activation of p21ras in murine myeloid cells transfected with human IL-2 receptor β chain

1 reference

12 December 2020

Farnesyl transferase inhibitors block the farnesylation of CENP-E and CENP-F and alter the association of CENP-E with the microtubules

1 reference

12 December 2020

Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor

1 reference

12 December 2020

IL-2 deprivation triggers apoptosis which is mediated by c-Jun N-terminal kinase 1 activation and prevented by Bcl-2.

1 reference

12 December 2020

Immunomodulatory effects of docetaxel on human lymphocytes

1 reference

12 December 2020

JAK3 inhibition as a new concept for immune suppression

1 reference

12 December 2020

Phospholipase Cgamma activates Ras on the Golgi apparatus by means of RasGRP1

1 reference

12 December 2020

Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance.

1 reference

12 December 2020

Cytokine regulation of apoptosis and Bcl-2 expression in lymphocytes of patients with systemic lupus erythematosus

1 reference

12 December 2020

Combination therapy of mycophenolate mofetil and rapamycin in prevention of chronic renal allograft rejection in the rat.

1 reference

12 December 2020

High-performance liquid chromatography/mass spectrometry characterization of Ki4B-Ras in PSN-1 cells treated with the prenyltransferase inhibitor L-778,123.

1 reference

12 December 2020

Stimulation of p21 ras upon T-cell activation

1 reference

12 December 2020

Preclinical and clinical pharmacodynamic assessment of L-778,123, a dual inhibitor of farnesyl:protein transferase and geranylgeranyl:protein transferase type-I

1 reference

12 December 2020

Flow cytometric quantitation of calcium-dependent and -independent mitogen-stimulation of T cell functions in whole blood: inhibition by immunosuppressive drugs in vitro

1 reference

12 December 2020

Regulation of Akt-dependent cell survival by Syk and Rac.

1 reference

12 December 2020

Cooperation between Syk and Rac1 leads to synergistic JNK activation in T lymphocytes

1 reference

12 December 2020

p21ras mediates control of IL-2 gene promoter function in T cell activation.

1 reference

12 December 2020

p21ras couples the T cell antigen receptor to extracellular signal-regulated kinase 2 in T lymphocytes.

1 reference

12 December 2020

In vivo evaluation of the novel calcineurin inhibitor ISATX247 in non-human primates

1 reference

12 December 2020

Isoprenoids and Ras: potential role in chronic rejection.

1 reference

12 December 2020

Farnesyltransferase and geranylgeranyltransferase I inhibitors in cancer therapy: important mechanistic and bench to bedside issues

1 reference

12 December 2020

The growth factor IL-2 activates p21ras proteins in normal human T lymphocytes

1 reference

12 December 2020

Regulatory T cells in transplantation tolerance

1 reference

12 December 2020

Vav1/Rac-dependent actin cytoskeleton reorganization is required for lipid raft clustering in T cells

1 reference

12 December 2020

Anions modulate the potency of geranylgeranyl-protein transferase I inhibitors

1 reference

12 December 2020

Synergistic interactions of cyclosporine and rapamycin to inhibit immune performances of normal human peripheral blood lymphocytes in vitro

1 reference

12 December 2020

Activation of p21-CDC42/Rac-activated kinases by CD28 signaling: p21-activated kinase (PAK) and MEK kinase 1 (MEKK1) may mediate the interplay between CD3 and CD28 signals

1 reference

12 December 2020

Regulatory T Cells in the Control of Transplantation Tolerance and Autoimmunity

1 reference

12 December 2020

Sirolimus (rapamycin) halts and reverses progression of allograft vascular disease in non-human primates

1 reference

12 December 2020

Increasing complexity of farnesyltransferase inhibitors activity: role in chromosome instability

1 reference

12 December 2020

p21ras and calcineurin synergize to regulate the nuclear factor of activated T cells

1 reference

12 December 2020

Prenylation inhibitors to treat proliferative renal disease

1 reference

12 December 2020

Lipid modifications of G proteins

1 reference

12 December 2020

Ligation of the T cell receptor complex results in activation of the Ras/Raf-1/MEK/MAPK cascade in human T lymphocytes

1 reference

12 December 2020

Anti-apoptotic signaling by the interleukin-2 receptor reveals a function for cytoplasmic tyrosine residues within the common gamma (gamma c) receptor subunit

1 reference

12 December 2020

10.1023/B:DRUG.0000047102.26698.08

Identifiers

DOI

1 reference

Dimensions Publication ID

10 December 2017

1009549315

0 references

1 reference